Brief: Grifols Gets FDA Approval For New Fibrinogen Concentrate, Fesiltytm

Grifols

19/12/2025 11:12

Dec 19 (Reuters) - Grifols SA GRLS.MC:

RECEIVES US FDA APPROVAL FOR NEW FIBRINOGEN CONCENTRATE, FESILTYTM (FIBRINOGEN, HUMAN-CHMT)

FESILTY EXPECTED TO BE AVAILABLE IN THE U.S. WITHIN THE FIRST HALF OF 2026

CONCENTRATE, FESILTY APPROVED IN THE U.S. FOR ACUTE BLEEDING EPISODES IN PEDIATRIC AND ADULT PATIENTS WITH CONGENITAL FIBRINOGEN DEFICIENCY

Source text

Further company coverage: GRLS.MC

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))